Registration Strip Icon for default Cadastre-se gratuitamente para obter cotações em tempo real, gráficos interativos, fluxo de opções ao vivo e muito mais.

AVGR

Avinger (AVGR)

Avinger Inc
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:AVGR
DataHoraFonteTítuloCódigoCompanhia
24/01/202523:35Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AVGRAvinger Inc
24/01/202518:32Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:AVGRAvinger Inc
24/01/202518:32Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:AVGRAvinger Inc
23/01/202518:31Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:AVGRAvinger Inc
24/12/202416:10AllPennyStocks.comThis Healthcare Stock Massively Outperformed The Market Before The HolidayNASDAQ:AVGRAvinger Inc
23/12/202410:30Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:AVGRAvinger Inc
11/12/202419:19Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:AVGRAvinger Inc
14/11/202417:23Edgar (US Regulatory)Form SC 13G - Statement of Beneficial Ownership by Certain InvestorsNASDAQ:AVGRAvinger Inc
13/11/202413:13Edgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:AVGRAvinger Inc
17/10/202417:33Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:AVGRAvinger Inc
08/08/202418:00Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:AVGRAvinger Inc
14/06/202401:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:AVGRAvinger Inc
03/06/202407:26Edgar (US Regulatory)Form SCHEDULE 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:AVGRAvinger Inc
31/05/202414:27Edgar (US Regulatory)Form SD - Specialized disclosure reportNASDAQ:AVGRAvinger Inc
24/05/202418:18Edgar (US Regulatory)Form S-1 - General form for registration of securities under the Securities Act of 1933NASDAQ:AVGRAvinger Inc
08/03/202418:31Edgar (US Regulatory)Form 8-K/A - Current report: [Amend]NASDAQ:AVGRAvinger Inc
14/02/202416:41Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:AVGRAvinger Inc
10/01/202419:11Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:AVGRAvinger Inc
09/08/202320:06Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:AVGRAvinger Inc
31/05/202317:46Edgar (US Regulatory)Specialized Disclosure Report (sd)NASDAQ:AVGRAvinger Inc
22/05/202317:31Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:AVGRAvinger Inc
17/03/202317:24Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:AVGRAvinger Inc
17/03/202317:07Edgar (US Regulatory)Amended Annual Report (10-k/a)NASDAQ:AVGRAvinger Inc
16/03/202307:04Edgar (US Regulatory)Annual Report (10-k)NASDAQ:AVGRAvinger Inc
10/11/202218:08Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:AVGRAvinger Inc
20/09/202219:39Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:AVGRAvinger Inc
07/09/202209:30GlobeNewswire Inc.BrightInsight Adds Medical Device and Biopharmaceutical Experts, Tamara Elias, M.D., and Scott Huennekens to Advisory CouncilNASDAQ:AVGRAvinger Inc
31/08/202209:31Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:AVGRAvinger Inc
31/08/202207:05Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:AVGRAvinger Inc
30/08/202217:06Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:AVGRAvinger Inc
 Apresentando as notícias mais relevantes sobre:NASDAQ:AVGR